Main Session
Sep
29
SS 25 - Nonmalignant 1: Advances in Radiotherapy for Nonmalignant Indications
248 - Toxicities and Quality of Life Following Observation or Radiation Therapy for Dupuytrens Disease in the International DEPART Randomized Trial
Presenter(s)

Jarad Martin, MD, MB, ChB, PhD, BSc FRANZCR GAustMS - Calvary Mater Newcastle Hospital, Newcastle, NSW